Success Story: Premium Processing Victory! Postdoctoral Scholar Earns NIW Approval
Client’s Testimonial:
“My attorney prepared a highly structured project summary that effectively highlighted the key contributions and strengthened the presentation of the case. This well-organized and insightful approach was instrumental in the successful approval of my I-140 NIW petition.”
On January 18th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Translational Cancer Research (Approval Notice).
General Field: Translational Cancer Research
Position at the Time of Filing: Postdoctoral Scholar
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: January 18th, 2025
Processing Time: 2 months (Premium Processing Requested)
Case Summary:
Our client, who holds a Ph.D. in pharmacology and toxicology, recently secured approval of an I-140 National Interest Waiver petition through premium processing. As an expert in translational cancer research, the client’s proposed endeavor focuses on identifying the critical mechanisms of antiandrogen drug resistance in order to develop novel targeted therapies for advanced prostate cancer. This work directly addresses one of the most pressing challenges in oncology today, drug resistance, and has significant implications for improving clinical outcomes for patients and advancing cancer care nationwide.
The client has established a strong track record of scholarly contributions, having authored 14 peer-reviewed journal articles, including three as first- or co-first author, along with five abstracts. Collectively, these publications have been cited 182 times, demonstrating that peers in the field recognize and rely upon this work to inform their own research. In addition, the client has completed at least 39 peer reviews for respected scientific journals, a clear marker of professional standing and expertise, as only leading researchers are entrusted with this responsibility.
The petition also highlighted the client’s ongoing investigations into prostate cancer treatment resistance, including efforts to validate novel compounds and uncover therapeutic targets. Evidence of the client’s impact was further bolstered by four strong letters of recommendation from established experts in the field, each attesting to the importance of the client’s research and the national benefits of continued work in this area.
“[Client] has proven to be an invaluable asset due to her outstanding and highly influential contributions to urological research and drug development. Her research achievements are
of great importance to the translational research of prostate cancer, underpinning future research excellence in this field within the United States.”
By documenting the client’s scholarly output, influence, and leadership in translational cancer research, the petition successfully demonstrated that the client is well-positioned to advance a project of clear, substantial merit and national importance. Ultimately, USCIS approved the NIW petition, recognizing the value of the client’s contributions and the critical role of this research in overcoming drug resistance and improving treatment outcomes for prostate cancer patients.